CD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapy
Author:
Publisher
Elsevier BV
Subject
General Biochemistry, Genetics and Molecular Biology
Reference75 articles.
1. Equivalence of Three or Four Cycles of Bleomycin, Etoposide, and Cisplatin Chemotherapy and of a 3- or 5-Day Schedule in Good-Prognosis Germ Cell Cancer: A Randomized Study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council
2. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J. Clin. Oncol.,2003
3. Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer;O’Shaughnessy;J. Clin. Oncol.,2014
4. Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity;Lesterhuis;Nat. Rev. Drug Discov.,2017
5. Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis;Schiavoni;Cancer Res.,2011
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of novel allogeneic cancer cells vaccine to treat colorectal cancer;Frontiers in Oncology;2024-07-24
2. STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance;Frontiers in Immunology;2024-03-14
3. Tretinoin improves the anti-cancer response to cyclophosphamide, in a model-selective manner;BMC Cancer;2024-02-13
4. Therapy-induced normal tissue damage promotes breast cancer metastasis;iScience;2024-01
5. The Role of TAMs in the Regulation of Tumor Cell Resistance to Chemotherapy;Critical Reviews™ in Oncogenesis;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3